KR20080027462A - 2-(1h-인돌릴술파닐)-아릴 아민 유도체 - Google Patents

2-(1h-인돌릴술파닐)-아릴 아민 유도체 Download PDF

Info

Publication number
KR20080027462A
KR20080027462A KR1020077029334A KR20077029334A KR20080027462A KR 20080027462 A KR20080027462 A KR 20080027462A KR 1020077029334 A KR1020077029334 A KR 1020077029334A KR 20077029334 A KR20077029334 A KR 20077029334A KR 20080027462 A KR20080027462 A KR 20080027462A
Authority
KR
South Korea
Prior art keywords
alk
disorder
methyl
phenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020077029334A
Other languages
English (en)
Korean (ko)
Inventor
얀 켈레르
카르스텐 율
모르텐 방 노르고르
Original Assignee
하. 룬트벡 아크티에 셀스카브
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하. 룬트벡 아크티에 셀스카브 filed Critical 하. 룬트벡 아크티에 셀스카브
Publication of KR20080027462A publication Critical patent/KR20080027462A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020077029334A 2005-06-17 2006-06-14 2-(1h-인돌릴술파닐)-아릴 아민 유도체 Withdrawn KR20080027462A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69200905P 2005-06-17 2005-06-17
US60/692,009 2005-06-17

Publications (1)

Publication Number Publication Date
KR20080027462A true KR20080027462A (ko) 2008-03-27

Family

ID=37532681

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077029334A Withdrawn KR20080027462A (ko) 2005-06-17 2006-06-14 2-(1h-인돌릴술파닐)-아릴 아민 유도체

Country Status (15)

Country Link
EP (1) EP1893575B1 (cg-RX-API-DMAC7.html)
JP (1) JP5144507B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080027462A (cg-RX-API-DMAC7.html)
CN (1) CN101238101A (cg-RX-API-DMAC7.html)
AR (1) AR054394A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006257288A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0611748A2 (cg-RX-API-DMAC7.html)
CA (1) CA2611566C (cg-RX-API-DMAC7.html)
EA (1) EA200800070A1 (cg-RX-API-DMAC7.html)
ES (1) ES2616095T3 (cg-RX-API-DMAC7.html)
IL (1) IL188064A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007014954A (cg-RX-API-DMAC7.html)
NO (1) NO20080265L (cg-RX-API-DMAC7.html)
WO (1) WO2006134499A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200710885B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010540461A (ja) * 2007-09-24 2010-12-24 ハー・ルンドベック・アクチエゼルスカベット セロトニン二重作用化合物に関する併用療法
TW200938189A (en) * 2008-03-13 2009-09-16 Lundbeck & Co As H [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
EP2606031B1 (en) 2010-08-20 2017-09-27 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
US9260416B2 (en) 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
US10179781B2 (en) * 2013-03-15 2019-01-15 Chromocell Corporation Sodium channel modulators for the treatment of pain
EP3046909A4 (en) 2013-09-17 2017-03-29 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
US9714240B2 (en) 2013-09-17 2017-07-25 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
US9850203B2 (en) 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
PE20160654A1 (es) 2013-11-22 2016-07-15 Pharmakea Inc Compuestos de inhibidor de autotaxina
CN116059203A (zh) 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117129A (en) * 1976-10-22 1978-09-26 Warner-Lambert Company Indolobenzoxazepines as cns depressants
ATE195125T1 (de) * 1995-11-06 2000-08-15 Dsm Nv Verfahren zur de-esterifikation
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
TW200400177A (en) * 2002-06-04 2004-01-01 Wyeth Corp 1-(Aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands
EP1701940B1 (en) * 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto

Also Published As

Publication number Publication date
EA200800070A1 (ru) 2008-04-28
AR054394A1 (es) 2007-06-20
BRPI0611748A2 (pt) 2016-11-22
ZA200710885B (en) 2009-03-25
WO2006134499A3 (en) 2007-04-12
NO20080265L (no) 2008-01-15
JP5144507B2 (ja) 2013-02-13
WO2006134499A2 (en) 2006-12-21
MX2007014954A (es) 2008-02-15
CA2611566C (en) 2011-08-16
EP1893575B1 (en) 2017-01-11
ES2616095T3 (es) 2017-06-09
CA2611566A1 (en) 2006-12-21
EP1893575A2 (en) 2008-03-05
JP2008546679A (ja) 2008-12-25
CN101238101A (zh) 2008-08-06
AU2006257288A1 (en) 2006-12-21
IL188064A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
US7737171B2 (en) Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
JP5144507B2 (ja) 2−(1h−インドリルスルファニル)−アリールアミン誘導体
KR20070036061A (ko) 정동 장애, 통증, adhd 및 스트레스성 요실금 치료에사용되는 2-(1h-인돌릴설파닐)아릴 아민 유도체
US20090192213A1 (en) Benzo[b]furane And Benzo[b]thiophene Derivatives
US7629473B2 (en) 2-(1H-indolylsulfanyl)-aryl amine derivatives
HK1120496A (en) 2-(1h-indolylsulfanyl)-aryl amine derivatives
EP1860100B1 (en) 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
HK1119674A (en) Benzo[b]furane and benzo[b]thiophene derivatives
HK1103075B (en) 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20071214

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid